Arcturus Therapeutics

Arcturus Therapeutics News & Events

SEC Filings

Filing date Description Form Filing Group Issuer View

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
ALCOBRA LTD. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
ALCOBRA LTD. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
ALCOBRA LTD. View HTML

Form of prospectus disclosing information facts events covered in both forms 424B1 424B3

424B4
Registration Statements
ALCOBRA LTD. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
ALCOBRA LTD. View HTML

Registration of up to an additional 20% of securities for an offering filed on an F-1

F-1MEF
Registration Statements
ALCOBRA LTD. View HTML

EFFECT

EFFECT
Other
ALCOBRA LTD. View HTML

This filing is a pre-effective amendment to an F-1 filing

F-1/A
Registration Statements
ALCOBRA LTD. View HTML

FWP

FWP
Other
ALCOBRA LTD. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
ALCOBRA LTD. View HTML

Copyright Morningstar